ZIMMER BIOMET HOLDINGS ($ZBH) posted quarterly earnings results on Wednesday, November 5th. The company reported earnings of $1.90 per share, beating estimates of $1.89 by $0.01. The company also reported revenue of $2,001,400,000, missing estimates of $2,024,715,548 by $-23,315,548.
You can see Quiver Quantitative's $ZBH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ZIMMER BIOMET HOLDINGS Insider Trading Activity
ZIMMER BIOMET HOLDINGS insiders have traded $ZBH stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by insiders over the last 6 months:
- LORI WINKLER (SVP and CHRO) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $309,960.
- SANG YI (Group President, Asia Pacific) has made 0 purchases and 3 sales selling 3,000 shares for an estimated $293,313.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ZIMMER BIOMET HOLDINGS Hedge Fund Activity
We have seen 406 institutional investors add shares of ZIMMER BIOMET HOLDINGS stock to their portfolio, and 485 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 6,772,287 shares (+inf%) to their portfolio in Q2 2025, for an estimated $617,700,297
- HARRIS ASSOCIATES L P added 3,732,101 shares (+inf%) to their portfolio in Q2 2025, for an estimated $340,404,932
- DODGE & COX added 2,533,009 shares (+12.9%) to their portfolio in Q2 2025, for an estimated $231,035,750
- CITADEL ADVISORS LLC removed 2,042,564 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $186,302,262
- VICTORY CAPITAL MANAGEMENT INC added 1,458,774 shares (+1769.9%) to their portfolio in Q2 2025, for an estimated $133,054,776
- CAMBER CAPITAL MANAGEMENT LP removed 1,250,000 shares (-55.6%) from their portfolio in Q2 2025, for an estimated $114,012,499
- JPMORGAN CHASE & CO removed 1,152,479 shares (-55.4%) from their portfolio in Q2 2025, for an estimated $105,117,609
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ZIMMER BIOMET HOLDINGS Government Contracts
We have seen $13,326,191 of award payments to $ZBH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 8511452441!OTHER MEDICAL: $523,078
- 4568909454!PERSONA INSTRUMENTS: $236,286
- BASE PLUS TWO YEAR SERVICE AGREEMENT. ROSA KNEE PREMIUM AND LITE WARRANTY: $197,500
- 4566620076!PECTUS BLU: $141,330
- 4566988495!PECTUS BLU: $119,242
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ZIMMER BIOMET HOLDINGS Congressional Stock Trading
Members of Congress have traded $ZBH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ZBH stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ZIMMER BIOMET HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $ZBH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/13/2025
- Rothschild & Co issued a "Buy" rating on 09/18/2025
- UBS issued a "Sell" rating on 08/08/2025
- Raymond James issued a "Outperform" rating on 08/08/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
To track analyst ratings and price targets for ZIMMER BIOMET HOLDINGS, check out Quiver Quantitative's $ZBH forecast page.
ZIMMER BIOMET HOLDINGS Price Targets
Multiple analysts have issued price targets for $ZBH recently. We have seen 9 analysts offer price targets for $ZBH in the last 6 months, with a median target of $113.0.
Here are some recent targets:
- Caitlin Roberts from Canaccord Genuity set a target price of $101.0 on 10/22/2025
- Ryan Zimmerman from BTIG set a target price of $122.0 on 10/13/2025
- Vijay Kumar from Evercore ISI Group set a target price of $104.0 on 10/07/2025
- Rick Wise from Stifel set a target price of $118.0 on 09/19/2025
- Ed Ridley-Day from Rothschild & Co set a target price of $130.0 on 09/18/2025
- Jayson Bedford from Raymond James set a target price of $113.0 on 08/08/2025
- Shagun Singh from RBC Capital set a target price of $115.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
